Cardiac effects of haloperidol and carbamazepine treatment. 1996

K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa

UI MeSH Term Description Entries
D008133 Long QT Syndrome A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME. Electrocardiogram QT Prolonged
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
April 1985, Journal of clinical psychopharmacology,
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
June 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
September 2009, The neurologist,
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
September 1995, Minerva cardioangiologica,
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
June 1998, Psychiatric services (Washington, D.C.),
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
June 1995, Clinical neuropharmacology,
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
January 1995, Journal of psychopharmacology (Oxford, England),
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
January 1995, Psychopharmacology bulletin,
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
June 1996, Clinical neuropharmacology,
K Iwahashi, and K Nakamura, and R Miyatake, and H Suwaki, and K Hosokawa
February 1984, Archives of general psychiatry,
Copied contents to your clipboard!